278 related articles for article (PubMed ID: 23931272)
21. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities.
Yen FL; Wu TH; Tzeng CW; Lin LT; Lin CC
J Agric Food Chem; 2010 Jun; 58(12):7376-82. PubMed ID: 20486686
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review.
Mahmood K; Zia KM; Zuber M; Salman M; Anjum MN
Int J Biol Macromol; 2015 Nov; 81():877-90. PubMed ID: 26391597
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of curcumin through autophagy modulation.
Forouzanfar F; Read MI; Barreto GE; Sahebkar A
IUBMB Life; 2020 Apr; 72(4):652-664. PubMed ID: 31804772
[TBL] [Abstract][Full Text] [Related]
24. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
Mohanty C; Das M; Sahoo SK
Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
[TBL] [Abstract][Full Text] [Related]
25. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.
Shabbir U; Rubab M; Tyagi A; Oh DH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375513
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective Effects and Mechanisms of Curcumin-Cu(II) and -Zn(II) Complexes Systems and Their Pharmacological Implications.
Yan FS; Sun JL; Xie WH; Shen L; Ji HF
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29283372
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective Effects of Curcumin in Neurodegenerative Diseases.
Genchi G; Lauria G; Catalano A; Carocci A; Sinicropi MS
Foods; 2024 Jun; 13(11):. PubMed ID: 38891002
[TBL] [Abstract][Full Text] [Related]
28. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson's disease.
Khatri DK; Juvekar AR
Pharmacol Biochem Behav; 2016; 150-151():39-47. PubMed ID: 27619637
[TBL] [Abstract][Full Text] [Related]
30. [Neuroprotective effect of curcumin and its potential use in the treatment of neurodegenerative diseases].
Górka M; Białoń N; Bieczek D; Górka D
Postepy Biochem; 2023 Mar; 69(1):18-25. PubMed ID: 37493562
[TBL] [Abstract][Full Text] [Related]
31. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.
Ghosh S; Banerjee S; Sil PC
Food Chem Toxicol; 2015 Sep; 83():111-24. PubMed ID: 26066364
[TBL] [Abstract][Full Text] [Related]
32. Curcumin, a Compound from Natural Sources, a True Scientific Challenge - A Review.
Stanić Z
Plant Foods Hum Nutr; 2017 Mar; 72(1):1-12. PubMed ID: 27995378
[TBL] [Abstract][Full Text] [Related]
33. Curcumin as Prospective Anti-Aging Natural Compound: Focus on Brain.
Benameur T; Soleti R; Panaro MA; La Torre ME; Monda V; Messina G; Porro C
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443381
[TBL] [Abstract][Full Text] [Related]
34. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease.
Fan S; Zheng Y; Liu X; Fang W; Chen X; Liao W; Jing X; Lei M; Tao E; Ma Q; Zhang X; Guo R; Liu J
Drug Deliv; 2018 Nov; 25(1):1091-1102. PubMed ID: 30107760
[TBL] [Abstract][Full Text] [Related]
35. Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations.
Nahar PP; Slitt AL; Seeram NP
J Med Food; 2015 Jul; 18(7):786-92. PubMed ID: 25490740
[TBL] [Abstract][Full Text] [Related]
36. Oral bioavailability of curcumin: problems and advancements.
Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
[TBL] [Abstract][Full Text] [Related]
37. Application of curcumin nanoformulations in Alzheimer's disease: prevention, diagnosis and treatment.
Lv H; Wang Y; Yang X; Ling G; Zhang P
Nutr Neurosci; 2023 Aug; 26(8):727-742. PubMed ID: 35694842
[No Abstract] [Full Text] [Related]
38. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.
Kumar P; Padi SS; Naidu PS; Kumar A
Methods Find Exp Clin Pharmacol; 2007; 29(1):19-25. PubMed ID: 17344940
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of curcumin.
Cole GM; Teter B; Frautschy SA
Adv Exp Med Biol; 2007; 595():197-212. PubMed ID: 17569212
[TBL] [Abstract][Full Text] [Related]
40. Curcumin: a potential neuroprotective agent in Parkinson's disease.
Mythri RB; Bharath MM
Curr Pharm Des; 2012; 18(1):91-9. PubMed ID: 22211691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
